Genus on track for full-year
Animal genetics group Genus has continued to trade in line with expectations during the four months to 31 October.
Animal genetics group Genus has continued to trade in line with expectations during the four months to 31 October.
The firm believes world agricultural markets have generally remained favourable for its customers and remains confident that its expectations for the full year will be met.
Adjusted operating profit continued to grow as expected, although this was partly offset by higher research and development (R&D) costs. The R&D costs were higher in part due to increased investment and slightly higher feed costs, while finance costs were lower.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The firm was keen to emphasise the overall adjusted profit before tax for the period was well ahead of last year.
Net debt at the end of October 2011 was £69.3m, slightly higher than at 30 June and significantly lower than at the same time last year (£79.7m).
The share price was down 0.89% to 1,000p at 14:12.
NR
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
8 of the best houses for sale with libraries
This week: the best houses for sale with libraries – from a five-storey Georgian townhouse in Bloomsbury, London, to a 15th-century property with a library in a medieval tower in Lozère, France
By Natasha Langan Published
-
Investors pull money from UK equities as government warns of “painful” Budget
The government’s post-election honeymoon period has been short-lived, and investors are shying away from UK equities as a result
By Katie Williams Published